Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 327 KiB)
Moniot, A.; Braux, J.; Bour, C.; Guillaume, C.; Lamret, F.; Allart-Simon, I.; Audonnet, S.; Renault, S.; Rédini, F.; Laronze-Cochard, M.; Sapi, J.; Gangloff, S.C.; Gérard, S.; Velard, F. Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo. Cancers 2021, 13, 5992. https://doi.org/10.3390/cancers13235992
Moniot A, Braux J, Bour C, Guillaume C, Lamret F, Allart-Simon I, Audonnet S, Renault S, Rédini F, Laronze-Cochard M, Sapi J, Gangloff SC, Gérard S, Velard F. Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo. Cancers. 2021; 13(23):5992. https://doi.org/10.3390/cancers13235992
Chicago/Turabian StyleMoniot, Aurélie, Julien Braux, Camille Bour, Christine Guillaume, Fabien Lamret, Ingrid Allart-Simon, Sandra Audonnet, Sarah Renault, Francoise Rédini, Marie Laronze-Cochard, Janos Sapi, Sophie C. Gangloff, Stéphane Gérard, and Frédéric Velard. 2021. "Pyridazinone Derivatives Limit Osteosarcoma-Cells Growth In Vitro and In Vivo" Cancers 13, no. 23: 5992. https://doi.org/10.3390/cancers13235992